Dental Bone Graft Substitutes Market worth 664.3 Million USD by 2021

The report "Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021", The global dental bone graft substitutes market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as technological advancements in the field of dental bone grafts and increase in the number of bone grafting procedures are expected to drive the growth of the global dental bone grafts substitutes market. Several insurance providers in the U.S. and various countries in the European region have assisted the medical sector to introduce and encourage the usage of latest synthetic bone grafts and demineralized allografts.

Browse 66 market data tables with 69 figures spread through 140 pages and in-depth TOC on "Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021" 
https://www.marketsandmarkets.com/Market-Reports/dental-bone-graft-substitutes-market-159678690.html
Early buyers will receive 10% customization on reports.

This report mainly considers four types of dental bone graft substitutes – xenograft, synthetic bone grafts, allograft, and demineralized allograft. Using patient’s own bone (autograft) has traditionally been the most preferred method of bone grafting; however, increasing technological advancements have increased the number of synthetic graft options. The benefits of synthetic grafts include availability, sterility, and reduced morbidity. Also, the synthetic bone grafts have a longer shelf life and there is no risk of any disease. Because of these benefits, synthetic bone graft is the fastest-growing type in the dental bone graft substitutes market.

In this report, the dental bone graft substitutes market is segmented into four major geographic segments, namely, North America, Europe, Asia-Pacific, and Rest of the World. Europe is estimated to account for the largest share of the overall dental bone graft substitutes market in 2016. Europe is the region of origin of implant dentistry; therefore, the penetration rate of dental bone graft substitutes is very high in this region. The main factors driving the growth of the European dental market are the increase in aging population, governmental expenditure on oral healthcare across Europe, and the high reimbursement rate although limited to Germany, Sweden, and the Netherlands.

This research study is aimed at identifying emerging trends and opportunities in the global dental bone graft substitutes market. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global dental bone graft substitutes market on the basis of type, application, product, and region.

https://www.marketsandmarkets.com/pdfdownload.asp?id=159678690

Apart from the market segmentation, this report also makes use of the Porter’s five forces analysis, which provides an in-depth analysis of the market by providing market dynamics, such as drivers, restraints, and opportunities in the global dental bone graft substitutes market.

Prominent players in this market include Institut Straumann AG (Switzerland), Geistlich (Switzerland) DENTSPLY International (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), BioHorizons IPH, Inc. (U.S.), ACE Surgical Supply Company, Inc. (U.S.), RTI Surgical, Inc. (U.S.), LifeNet Health (U.S.), and Dentium (Korea).

Vaccine Adjuvants Market worth 769.4 Million USD by 2021

The report "Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021", report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the vaccine adjuvants market along with the estimates and forecasts of the revenue and market share analysis.

Browse 90 market data tables with 42 figures spread through 156 pages and in-depth TOC on "Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021" 
https://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html
Early buyers will receive 10% customization on reports.

The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016 at a CAGR of 10.5% from 2016 to 2021. The major factors driving the growth of this market are high prevalence of infectious and zoonotic diseases, increasing focus on immunization programs by various government bodies, and growing focus on improved and long-lasting immunization against existing and emerging diseases.

The report segments this market into product type, route of administration, disease type, applications, and application categories. On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. Particulate adjuvants are expected to account for the largest share of the market. Adjuvant emulsions, on the other hand, are projected to grow at the highest CAGR from 2016 to 2021 due to factors such as the proven efficacy and relatively fewer safety issues involved in the use of adjuvant emulsions.

On the basis of route of administration, the vaccine adjuvants market is segmented into oral, subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. The rapidly growing geriatric population and increasing need for development of better vaccines for improved immunization are the key factors propelling the growth of this market.

On the basis of disease type, the vaccine adjuvants market includes infectious diseases, cancer, and other diseases. The infectious diseases segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. High incidences of diseases and research investments in life sciences are the major factors driving the growth of this market.

Based on applications, the global vaccine adjuvants market is segmented into research and commercial applications. Research applications are expected to account for the largest share of the market during the forecast period. Growth in this segment is driven by factors such as increasing need for better immunization for the increasing geriatric population and increasing government funding in research to meet the unmet needs for safe and effective vaccine adjuvants.

https://www.marketsandmarkets.com/pdfdownload.asp?id=152603894

On the basis of application categories, the vaccine adjuvants market is segmented into human and veterinary adjuvants. Adjuvants for humans are expected to account for the largest share of the global vaccine adjuvants market in 2016 and are expected to grow at a higher CAGR in the application category segment.

The key players in the vaccine adjuvants market include Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

Pain Management Devices Market worth 4.64 Billion USD by 2021

The report "Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Browse 117 market data tables with 43 figures spread through 198 pages and in-depth TOC on "Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021" 
https://www.marketsandmarkets.com/Market-Reports/pain-management-devices-market-91418163.html
Early buyers will receive 10% customization on reports.

This report studies the global pain management devices market over the forecast period of 2016 to 2021. The market is expected to reach ~USD 4.64 Billion by 2021, at CAGR of 8.5% from 2016 to 2021.A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global pain management devices market. On the other hand, factors such as low awareness regarding the availability and use of pain management device, shortage of pain specialists, low number of pain clinics in several countries, existence of a gap in prevalence and treatment of chronic pain, and high procedural and purchase cost of pain management device are restricting the growth of the global market.

This report covers three major pain management device types, namely, neurostimulation devices, ablation devices, and analgesic infusion pumps. The neurostimulation devices segment is expected to witness the highest growth and account for the largest share of the pain management devices market in 2016. This can be attributed to the advantages of neurostimulation over alternative therapies for managing chronic pain. Also, the long-term cost efficiency and technological developments in neurostimulation devices are contributing to the growth of this market segment.

On the basis of application, the global pain management device market is segmented into neuropathic pain, cancer pain, facial pain & migraine, musculoskeletal pain, and others. The neuropathic pain application segment is estimated to witness the highest growth during the forecast period, primarily due to the presence of substantial clinical evidence in the favor of high efficacy of pain management device in neuropathic pain treatment, favorable reimbursement scenario, development of novel neuropathic pain management device, large patient population base, rising geriatric population across the globe, and side effects of drugs used to treat neuropathic pain.

Based on the mode of purchase, the market is segmented into over-the-counter (OTC) devices and prescription-based devices. The prescription-based devices segment is expected to account for the largest share of the global pain management devices market in 2016, whereas the OTC devices segment is expected to grow at the highest CAGR during the forecast period. The high growth in this segment is attributed to the availability of a number of OTC devices in the market and FDA approvals for new OTC devices in the coming years.

https://www.marketsandmarkets.com/pdfdownload.asp?id=91418163

As of 2016, North America held the largest share of the global pain management devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors, including growing incidence of chronic diseases, improving healthcare infrastructure in the region, growing middle-class population and disposable income levels, and rising awareness about the safety and efficacy of pain management device are stimulating the growth of the pain management devices market in the Asia-Pacific region.

Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), and St. Jude Medical Inc. (U.S.) are the major players in the global pain management devices market.

Dental Digital X-ray Market worth 3,290.6 Million USD by 2020

The report "Dental Digital X-ray Market by Product (Digital, Analog), Type (Intraoral, Extraoral (CBCT, Panoramic), Hybrid X-ray), Application (Diagnostic, Therapeutics, Forensic), End User (Dental Clinics, Forensic Laboratories) - Global Forecast to 2020", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).

Browse 174 market data Tables and 46 Figures spread through 194 Pages and in-depth TOC on "Dental Digital X-ray Market by Product (Digital, Analog), Type (Intraoral, Extraoral (CBCT, Panoramic), Hybrid X-ray), Application (Diagnostic, Therapeutics, Forensic), End User (Dental Clinics, Forensic Laboratories) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/dental-digital-x-ray-market-102002511.html
Early buyers will receive 10% customization on reports.

The global dental digital X-ray market is expected to reach 3,290.6 Million by 2020 from USD 2,154.0 in 2015, at a CAGR of 8.8% during the forecast period. Factors such as technological advancements, rapidly growing geriatric population, ability of digital systems to reduce diagnosis time and provide improved image quality, growing adoption of cone-beam computed tomography (CBCT), increase in dental disorders, and the growing demand for cosmetic dentistry are propelling the dental digital X-ray imaging market during the forecast period.

In this report, the dental digital X-ray imaging market is segmented on the basis of type, application, end user, and region. On the basis of type, the market is segmented into extraoral X-ray systems and hybrid X-ray systems. The extraoral X-ray systems segment accounted for the largest market share in 2015. This segment is further categorized into panoramic/cephalometric X-ray systems and cone-beam computed tomography (CBCT) systems. The intraoral X-ray systems are further segmented into PSP (Photostimulable phosphor) systems and digital sensors. Digital sensors segment accounted for the largest market share in 2015 and will continue to dominate the market in the forecast period. The large share of this segment can be attributed to the significant reduction in operating time and excellent-quality images obtained from these sensors as compared to PSP systems.

Geographically, the dental digital X-ray market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of this market in 2015. However, the Asian market is expected to grow at the highest CAGR. Growth in the Asian market can be attributed to growth in the geriatric population, focus of emerging and leading market players to expand their presence in the developing Asian markets, rise in disposable income, less stringent regulatory guidelines, improving healthcare infrastructure, and growth in medical tourism in the region.

https://www.marketsandmarkets.com/Market-Reports/dental-digital-x-ray-market-102002511.html

The dental digital X-ray imaging market is highly competitive, encompassing a range of major as well as emerging players. Danaher Corporation (U.S.), Carestream Health, Inc. (U.S.), Sirona Dental Systems, Inc. (U.S.), Planmeca Oy (Finland), Vatech Co. Ltd. (South Korea), LED Medical Diagnostics (Canada), The Yoshida Dental MFG.Co. Ltd. (Japan), Midmark Corporation (U.S.), Air Techniques, Inc. (U.S.), and Cefla s.c. (Italy) are prominent players in this market.

Optical Imaging Market worth 1.75 Billion USD by 2020

The report "Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) - Global Forecast to 2020", The Global Optical Imaging Market Is Expected to reach USD 1,749.2 Million by 2020. The market was valued at USD 989.0 Million in 2015 and is expected to grow at a CAGR of 12.1% from 2015 to 2020.

Browse 161 market data Tables and 43 Figures spread through 200 Pages and in-depth TOC on "Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/optical-imaging-technologies-market-894.html
Early buyers will receive 10% customization on reports.

Owing to the technological advancements and increasing application areas of optical imaging techniques in pharmaceutical and biotechnological industries and medical diagnostics & therapeutics, the optical imaging market recorded a healthy growth rate during last decade. Optical imaging is extensively used for several applications including preclinical research, disease diagnosis, imaging of various cellular and molecular processes in vivo including protein interactions, protein degradation, and protease activity. Thus, increasing research activities in the biopharmaceutical industry and rising applications of optical imaging modalities for therapeutic and diagnostic purposes is expected to have a positive impact on the growth of this market. Moreover, uptake of optical imaging techniques due to growing demand for non-invasive & non-ionizing imaging modalities with ageing population and integration of optical imaging techniques with other imaging modalities is expected to drive the demand for optical imaging products in the coming years. However, high installation cost, complex regulatory requirements, and lack of skilled operators is likely to hinder the growth of the market to a certain extent.

In this report, the global optical imaging market is segmented by techniques, products, applications, end users, geographic regions, and countries. It also discusses the key market drivers, restraints, opportunities, trends, and challenges of this market and its sub-markets.

In 2013, North America accounted for the largest share of the global optical imaging market, followed by Europe and Asia-Pacific. Greater uptake of optical imaging products and the presence of large number of optical imaging products manufacturers in the North American and European region has led to their large market share in the optical imaging market. However, the Asia-Pacific region represents the substantial growth opportunity for the optical imaging market during the forecast period of 2015 to 2020. The growth in this region is primarily driven by increased focus on healthcare growth in geriatric population, rising per capita income, increasing investments in the APAC healthcare industry by key market players, rising demand for cutting-edge technologies, and low labor costs.

https://www.marketsandmarkets.com/pdfdownload.asp?id=894

The prominent players in the optical imaging market include Carl Zeiss Meditec AG (Germany), Bioptigen, Inc. (U.S.), Topcon Medical Systems, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Canon, Inc. (U.S.), and PerkinElmer, Inc. (U.S.),

About MarketsandMarkets

MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Patient Portal Market worth 2.74 Billion USD by 2020

The report “Patient Portal Market - by Type (Standalone, and Integrated portal), by Delivery Mode (Web-Based, and Cloud- Based), & by End Users (Providers, Payers, Pharmacies, and Others) - Analysis & Global Forecast to 2020”, analyzes and studies the major market drivers, restraints/challenges, opportunities, key players, competitive landscape and geographical markets. This report studies the global patient portal market for the forecast period of 2015 to 2020. This market is expected to reach USD 2.74 Billion by 2020 from USD 1.19 Billion in 2015, at a CAGR of 18.1%.

Browse 80 tables and 32 figures spread through 161 Pages and in-depth TOC on "Patient Portal Market - by Type (Standalone, and Integrated portal), by Delivery Mode (Web-Based, and Cloud- Based), & by End Users (Providers, Payers, Pharmacies, and Others) - Analysis & Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/patient-portal-market-49094801.html
Early buyers will receive 10% customization on reports.

The global patient portal market is segmented on the basis of type, delivery mode, end user, and region.

By type, the patient portal market is categorized into standalone and integrated patient portals. The integrated portals are estimated to account for the largest share of the global patient portal market, by type, in 2015. This large share can be attributed to the fact that most of the integrated portals are provided by the same vendor as an electronic health record (EHR) system. These solutions allow a user to complete multiple business functions from within the same interface. As they provide a one-stop solution, they are cheaper, favored, and therefore high in demand.

On the basis of delivery mode, the market is segmented into web-based and cloud-based modes. In 2015, web-based mode of delivery is expected to command the largest share of the global patient portal market. However, the cloud-based mode of delivery is expected to grow at a higher CAGR due to its advantages—cloud-based services can help healthcare organizations share and integrate information from disparate locations or systems in real time and generate a database registry.

The patient portal market has been further segmented by end users into providers, payers, pharmacies, and others. Providers include hospitals, ambulatory care centers, home healthcare agencies, nursing homes, diagnostic & imaging centers, and physicians. Other end users include employer groups and government entities. In 2015, the providers’ segment is expected to command the largest share of the global patient portal market, by end user. Rising mandates for incentive programs for providers; government initiatives to improve the quality of care delivered to patients and curtail the soaring cost of healthcare among providers; and the growing need to improve the affordability and accessibility of healthcare services are some factors propelling the use of patient portal solutions among providers.

On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America is poised to account for the largest share of the patient portal market, followed by Europe and Asia-Pacific. However, the European region is slated to grow at the highest CAGR during the forecast period. The large share of the North American patient portal market can primarily be attributed to the federal mandates in the U.S., rising number of accountable care organizations in the U.S., rising aging population in the U.S., Canada’s efforts to enhance healthcare delivery, and digital health measures in Canada.

https://www.marketsandmarkets.com/pdfdownload.asp?id=49094801

Federal mandates like the Meaningful Use incentives, growing patient-centric approach in healthcare delivery, increasing EHR adoption, and growing popularity of patient portals among the elderly are some factors expected to drive the growth of the global patient portal market in the coming years.

Allscripts Healthcare Solutions, Inc. (U.S.), McKesson Corporation (U.S.), athenahealth, Inc. (U.S.), Cerner Corporation (U.S.), eClinicalWorks (U.S.), CureMD (U.S.), NextGen Healthcare Information Systems, LLC (U.S.), Greenway Health, LLC (U.S.), Medfusion (U.S.), Epic Corporation Inc. (U.S.), GE Healthcare (U.K.), and Intelichart (U.S.) are some of the key players in the patient portal market worldwide.

Medical Automation Market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020.

The report "Medical Automation Market by Application (Diagnostics & Monitoring, Therapeutics, Lab & Pharmacy Automation, Medical Logistics & Training), End-User (Hospital, Diagnostic Center, Research Institute, Home/Ambulatory Care) - Global Forecast to 2020" , analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

Browse 92 market data Tables and 53 Figures spread through 194 Pages and in-depth TOC on "Medical Automation Market by Application (Diagnostics & Monitoring, Therapeutics, Lab & Pharmacy Automation, Medical Logistics & Training), End-User (Hospital, Diagnostic Center, Research Institute, Home/Ambulatory Care) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/medical-automation-technologies-market-848.html
Early buyers will receive 10% customization on reports.

This report studies the global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020.

On the basis of application, the medical automation market is divided into four major segments, namely, diagnostic and monitoring automation (automated imaging, automated image analysis, and point-of-care testing), therapeutic automation (non-surgical automation and surgical automation), laboratory and pharmacy automation (laboratory automation and pharmacy automation), and medical logistics and training (logistics automation and trainers). The therapeutic automation segment is estimated to hold the largest share of the global medical automation market in 2015. Increasing application of automated devices (such as defibrillators, surgical robots, surgical navigation systems, and automated medication systems) in therapeutics and rising incidences of various chronic diseases are driving the growth of this market segment.

On the basis of end users, the global medical automation market is divided into four segments, namely, hospitals and diagnostic centers, pharmacies, research laboratories and institutes, and home/ambulatory care settings and other end users.

A number of factors such as rising government support for medical automation, growing need for reproducibility and accuracy during medical procedures, investments by venture capitalists and collaborations to promote automated medical devices, and technological advancements are fueling the demand for automation in the healthcare industry. Additionally, increasing use of automation in various research activities, rising cost of labor, and rising number of research studies in emerging nations are some other factors contributing to the growth of the medical automation market. On the other hand, stringency of regulatory procedures leading to delay in product launches and high cost of automated solutions are the key factors hampering the growth of the global medical automation market.

As of 2015, North America is estimated to hold the largest share of the global medical automation market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 11.6% from 2015 to 2020. Presence of a large geriatric population; increasing prevalence of CVDs, diabetes, and cancer; rising number of clinical research activities; and growing government expenditure on healthcare and life sciences research are propelling the growth of the Asia-Pacific medical automation market.

https://www.marketsandmarkets.com/pdfdownload.asp?id=848

Koninklijke Philips N.V. (Netherlands), Siemens AG, (Germany), General Electric Company (U.S.), Medtronic plc. (U.S.), Tecan Group Ltd. (Switzerland), Intuitive Surgical, Inc. (U.S.), Stryker Corporation (U.S.), Accuray Incorporated (U.S.), Danaher Corporation (U.S.), and Swisslog Holding AG (Switzerland) are some of the key players operating in the global medical automation market.

Cosmetic Dentistry Market worth $22,362.4 Million by 2020

The report “Cosmetic Dentistry Market by Product (Dental Implants, Dental Bridges, Dental Crowns, Orthodontic Braces, Dental Lasers, Dental Veneers, Dental Handpieces, Bonding Agents, Dental Lasers, Dental Chairs, CAD/CAM Systems) - Global Forecast to 2020”, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World

Browse 162 market data tables and 42 figures spread through 213 pages and in-depth TOC on “Cosmetic Dentistry Market by Product (Dental Implants, Dental Bridges, Dental Crowns, Orthodontic Braces, Dental Lasers, Dental Veneers, Dental Handpieces, Bonding Agents, Dental Lasers, Dental Chairs, CAD/CAM Systems) - Global Forecast to 2020”
https://www.marketsandmarkets.com/Market-Reports/cosmetic-dentistry-market-3096361.html
Early buyers will receive 10% customization on reports.

This report studies the global cosmetic dentistry market during the forecast period of 2015 to 2020. The global market is expected to grow at a CAGR of 6.8% during the forecast period to reach USD 22,362.4 Million by 2020. Growth in this market is attributed to rising disposable incomes of the middle-class population, growing consumer awareness about cosmetic dentistry, and rising focus on dental aesthetics. However, a lack of reimbursement and the high cost of dental imaging systems are expected to restrain the growth of this market to a certain extent.

The global cosmetic dentistry market is segmented by product and region. This report also discusses the key drivers, restraints, opportunities, and challenges for this market. On the basis of product, the market is segmented into dental systems & equipment, dental implants, dental bridges, dental veneers, dental crowns, orthodontic braces, inlays & onlays, and bonding agents. The dental systems and equipment market is further sub-segmented into instrument delivery systems, dental chairs, handpieces, light cure equipment, CAD/CAM systems, scaling units, dental lasers, and dental radiology equipment. The dental radiology equipment segment is categorized into extra-oral radiology equipment, intra-oral radiology equipment, and cone beam computed tomography (CBCT) scanners. The dental implants market covers titanium implants and zirconium implants. The dental bridges market is sub-segmented into traditional bridges, cantilever bridges, and Maryland bridges. The orthodontic braces market is sub-segmented into fixed braces and removable braces.

In 2014, dental systems and equipment market accounted for the largest share of the cosmetic dentistry market. This is majorly due to the wide applications of dental equipment and systems in different dental procedures. The rising use of CAD/CAM systems for milling different prosthetics such as crowns, veneers, bridges, and inlays and onlays for cosmetic dental procedure have also contributed to the high share of this market.

https://www.marketsandmarkets.com/pdfdownload.asp?id=3096361

On the basis of region, the market is broadly segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The presence of a large number of dental manufacturers, increasing awareness among consumers, and advancements in dental technology has led to the high shares of Europe and North America in this market. However, the Asia-Pacific region is expected to grow at the highest CAGR owing to rapidly developing healthcare infrastructure, increasing per capita incomes, growing middle-class population, and rising dental tourism in emerging countries of this region.

Major players in the market include 3M Company (U.S.), Danaher Corporation (U.S.), DENTSPLY International, Inc. (U.S.), Institut Straumann AG (Switzerland), Zimmer Biomet Holding, Inc. (U.S.), Align Technology, Inc. (U.S.), Sirona Dental Systems, Inc. (U.S.), Biolase, Inc. (U.S.), Planmeca Oy (Finland), and A-dec Inc. (U.S.).

Clinical Trial Supplies Market worth 1.2 Billion USD by 2020

The report “Clinical Trial Supplies Market by products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the clinical trial supplies market along with the estimates and forecasts of the revenue and market share analysis.

Browse 70 tables and 36 figures spread through 134 pages and in-depth TOC on "Clinical Trial Supplies Market by products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html
Early buyers will receive 10% customization on reports.

The global clinical trial supplies market is expected to reach USD 1,274.3 Million by 2020 from USD 904.3 Million in 2015, at a CAGR of 7.1% from 2015 to 2020.

The report segments this market based on products and services, phases, therapeutic areas, and regions. Among the various products and services, the logistics and distribution services segment is expected to account for the largest share of the market and is projected to grow at the highest CAGR from 2015 to 2020. The high growth in this segment can be attributed to the factors such as globalization of clinical trials and increasing outsourcing of services.

On the basis of phases, the clinical trial supplies market is segmented into phase I, phase II, and phase III. The phase III segment is expected to account for the largest share of the global clinical trial supplies market in 2015. Large sample size of patients and high cost of phase III trials are the factors propelling the growth of this market.

https://www.marketsandmarkets.com/pdfdownload.asp?id=172240059

Therapeutic areas, included in the clinical trial supplies market are oncology, cardiovascular diseases, respiratory diseases, CNS and mental disorders, dermatology disorders, blood disorders, infectious diseases, and others. The oncology segment is expected to account for the largest share of the global clinical trial supplies market in 2015. Increase in cancer incidences and government funding for cancer research are factors driving the growth of this market.

Based on regions, the global clinical trial supplies market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising prevalence of chronic diseases, growing number of clinical trials, and the increasing number of life sciences research activities in North America.

Key players in the clinical trial supplies market include Alamc Group LTD (U.K.), Biocair (U.K.), Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services (U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services (U.S.), and Thermo Fisher Scientific, Inc. (U.S.)

Protein Engineering Market worth $1,463.0 Million by 2020

The report “Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020”, provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.

   

Browse 100 market data tables and 53 figures spread through 180 pages and in-depth TOC on “Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/protein-antibody-engineering-market-898.html
Early buyers will receive 10% customization on reports.

The global protein engineering market is poised to reach $1,463.0 million by 2020 from $610.3 million in 2014, at a CAGR of 15.7% from 2015 to 2020.

Factors such as increase in adoption of protein drugs over non-protein drugs, high prevalence rate of lifestyle diseases, growth in funding for protein engineering, and reduction in overall timeline and cost for drug discovery are the major drivers of the protein engineering market. However, expensive and high maintenance tools and instruments used in protein engineering and dearth of trained personnel are hindering the market.

The protein engineering market is segmented on the basis of product, technology, protein type, end user, and region. By product, the protein engineering market is categorized into instruments, reagents, and services and software. The instruments segment accounted for the largest share 41.4% of the global protein engineering market in 2014.

The protein engineering technology market is categorized into rational protein design, and irrational protein design. In this market, rational protein design is the largest and fastest growing segment. On the basis of end user the protein engineering market is classified into academic research institutes, pharmaceutical and biotechnology companies, and contract research organizations. In this market, pharmaceutical and biotechnology companies segment holds the major share followed by contract research organizations.

Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies is the largest as well as fastest growing segment of the protein engineering protein type market. This growth is attributed to the increase in adoption of them for various therapies such as cancer and autoimmune diseases.

https://www.marketsandmarkets.com/pdfdownload.asp?id=898

On the basis of geography, the protein engineering market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is further segmented into U.S. and Canada. Asia is further segmented into China, Japan, India and Rest of Asia. In 2014, North America accounted for the largest share of the protein engineering market, followed by Europe. Both markets are estimated to register double-digit growth rates over the next five years.

Key players operating in the protein engineering market are Agilent Technologies (U.S.), AB-Sciex (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).

Endodontics Market worth 1.61 Billion USD by 2022

The report "Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022", The global endodontics market is projected to reach USD 1.61 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 5.1% during the forecast period. Growth in this market is attributed to the rapid growth in the geriatric population, increasing number of dentists and dental practices, rising dental tourism, increasing dental expenditure, and an increase in disposable incomes.

Browse 194 Market Data Tables and 27 Figures spread through 193 Pages and in-depth TOC on "Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/endodontics-market-222473576.html
Early buyers will receive 10% customization on reports.

The consumables segment to dominate the endodontics market during the forecast period

Based on product, the endodontics market is segmented into consumables and instruments. The consumables segment accounted for the major share of the global endodontics market and is also expected to register the highest CAGR during the forecast period. The large share and high growth of this segment can primarily be attributed to the growing number of root canal procedures globally.

Dental clinics to witness the highest growth rate during the forecast period

On the basis of end users, the endodontics market is segmented into dental clinics, dental hospitals, and dental academic & research institutes. The dental clinics segment accounted for the major share of the global endodontics market and is also expected to register the highest CAGR during the forecast period. The large share of this end-user segment is attributed to the increasing number of dental clinics especially in emerging markets, rapid adoption of advanced technologies in these settings, and growth in the target patient population.

Europe dominated the market in 2016

Europe accounted for the largest share of the endodontics market in 2016, followed by North America. The large share of this region is attributed to the increasing prevalence of dental diseases, growth in the aging population, increasing demand for advanced dental procedures, growing dental tourism in some European countries, increasing number of dental clinics and hospitals, and increasing dental care expenditure in countries such as Germany and the UK.

The prominent players in the endodontics market are DENTSPLY SIRONA (US), Danaher Corporation (US), Ivoclar Vivadent (Liechtenstein), Ultradent Products (US), Septodont Holding (France), FKG Dentaire (Switzerland), Brasseler USA (US), MICRO-MEGA (France), DiaDent Group International (Canada), MANI (Japan), COLTENE Holding (Switzerland), and VOCO (Germany).

Clinical Trial Supplies Market worth 1.2 Billion USD by 2020

The report “Clinical Trial Supplies Market by products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the clinical trial supplies market along with the estimates and forecasts of the revenue and market share analysis.

Browse 70 tables and 36 figures spread through 134 pages and in-depth TOC on "Clinical Trial Supplies Market by products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html
Early buyers will receive 10% customization on reports.

The global clinical trial supplies market is expected to reach USD 1,274.3 Million by 2020 from USD 904.3 Million in 2015, at a CAGR of 7.1% from 2015 to 2020.

The report segments this market based on products and services, phases, therapeutic areas, and regions. Among the various products and services, the logistics and distribution services segment is expected to account for the largest share of the market and is projected to grow at the highest CAGR from 2015 to 2020. The high growth in this segment can be attributed to the factors such as globalization of clinical trials and increasing outsourcing of services.

On the basis of phases, the clinical trial supplies market is segmented into phase I, phase II, and phase III. The phase III segment is expected to account for the largest share of the global clinical trial supplies market in 2015. Large sample size of patients and high cost of phase III trials are the factors propelling the growth of this market.

https://www.marketsandmarkets.com/pdfdownload.asp?id=172240059

Therapeutic areas, included in the clinical trial supplies market are oncology, cardiovascular diseases, respiratory diseases, CNS and mental disorders, dermatology disorders, blood disorders, infectious diseases, and others. The oncology segment is expected to account for the largest share of the global clinical trial supplies market in 2015. Increase in cancer incidences and government funding for cancer research are factors driving the growth of this market.

Based on regions, the global clinical trial supplies market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising prevalence of chronic diseases, growing number of clinical trials, and the increasing number of life sciences research activities in North America.

Key players in the clinical trial supplies market include Alamc Group LTD (U.K.), Biocair (U.K.), Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services (U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services (U.S.), and Thermo Fisher Scientific, Inc. (U.S.)

Neuromodulation Market worth $6.20 Billion by 2020

The report “Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020” analyzes and studies the major market drivers, restraints, and opportunities.

Browse 84 market data tables and 32 figures spread through 182 pages and in-depth TOC on “Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html
Early buyers will receive 10% customization on reports.

This report studies the global neuromodulation market from 2015 to 2020. The global neuromodulation market is estimated at $3.65 Billion in 2015, and is projected to reach $6.20 Billion by 2020, at a CAGR of 11.2% during the forecast period. The global neuromodulation market is segmented on the basis of technology, application, and region.

Based on technology, the neuromodulation market is segmented into internal neuromodulation and external neuromodulation. Internal neuromodulation is further segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), and gastric electrical stimulation (GES). External neuromodulation is categorized into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES).

Based on application, the neuromodulation market is segmented into technology-wise applications, such as spinal cord stimulation (chronic pain, failed back surgery, ischemia); deep brain stimulation (Parkinsons disease, tremor, depression, others); sacral nerve stimulation (urine incontinence, fecal incontinence); vagus nerve stimulation (epilepsy, others); gastric electrical stimulation (gastro paresis, obesity); transcutaneous electrical nerve stimulation (treatment resistant depression, others); and transcranial magnetic stimulation (depression, migraine headaches).

https://www.marketsandmarkets.com/pdfdownload.asp?id=921

On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and rest of the world (RoW). The rest of the world region comprises Latin America, the Middle East, and Africa. North America is expected to account for the largest share of the neuromodulation market, followed by Europe, Asia-Pacific, and rest of the world (RoW) in 2015.

Factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by players, and expanded target applications and new indications are driving the growth of this market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals are hindering its market growth.

Some of the major players in the global neuromodulation market include Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.), Neurosigma, Inc. (U.S.), Neuropace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), and BioControl Medical (Israel).

Pain Management Devices Market worth 4.64 Billion USD by 2021

The report "Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Browse 117 market data tables with 43 figures spread through 198 pages and in-depth TOC on "Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021" 
https://www.marketsandmarkets.com/Market-Reports/pain-management-devices-market-91418163.html
Early buyers will receive 10% customization on reports.

This report studies the global pain management devices market over the forecast period of 2016 to 2021. The market is expected to reach ~USD 4.64 Billion by 2021, at CAGR of 8.5% from 2016 to 2021.A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global pain management devices market. On the other hand, factors such as low awareness regarding the availability and use of pain management device, shortage of pain specialists, low number of pain clinics in several countries, existence of a gap in prevalence and treatment of chronic pain, and high procedural and purchase cost of pain management device are restricting the growth of the global market.

https://www.marketsandmarkets.com/pdfdownload.asp?id=91418163

This report covers three major pain management device types, namely, neurostimulation devices, ablation devices, and analgesic infusion pumps. The neurostimulation devices segment is expected to witness the highest growth and account for the largest share of the pain management devices market in 2016. This can be attributed to the advantages of neurostimulation over alternative therapies for managing chronic pain. Also, the long-term cost efficiency and technological developments in neurostimulation devices are contributing to the growth of this market segment.

On the basis of application, the global pain management device market is segmented into neuropathic pain, cancer pain, facial pain & migraine, musculoskeletal pain, and others. The neuropathic pain application segment is estimated to witness the highest growth during the forecast period, primarily due to the presence of substantial clinical evidence in the favor of high efficacy of pain management device in neuropathic pain treatment, favorable reimbursement scenario, development of novel neuropathic pain management device, large patient population base, rising geriatric population across the globe, and side effects of drugs used to treat neuropathic pain.

https://www.marketsandmarkets.com/requestsample.asp?id=91418163

Based on the mode of purchase, the market is segmented into over-the-counter (OTC) devices and prescription-based devices. The prescription-based devices segment is expected to account for the largest share of the global pain management devices market in 2016, whereas the OTC devices segment is expected to grow at the highest CAGR during the forecast period. The high growth in this segment is attributed to the availability of a number of OTC devices in the market and FDA approvals for new OTC devices in the coming years.

As of 2016, North America held the largest share of the global pain management devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors, including growing incidence of chronic diseases, improving healthcare infrastructure in the region, growing middle-class population and disposable income levels, and rising awareness about the safety and efficacy of pain management device are stimulating the growth of the pain management devices market in the Asia-Pacific region.

Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), and St. Jude Medical Inc. (U.S.) are the major players in the global pain management devices market.

Patient Access Solutions Market worth 1.74 Billion USD by 2022

The report "Patient Access Solutions Market by Product & Service (Eligibility Verification, Medical Necessity, Prior-authorization, Denial Management), Delivery Mode (Web & Cloud, On-premise), End User (Providers, Outsourcing Companies) - Global Forecast to 2022", The patient access solutions market is expected to reach USD 1.74 Billion by 2022 from an estimated USD 1.21 Billion in 2017, at a CAGR of 7.6%. Regulatory compliance encouraging the use of patient access solutions, increasing patient volume and the subsequent growth in the demand for health insurance, growing importance of denial management, declining reimbursement rates, and need to curtail escalating healthcare costs are the major factors driving the growth of the patient access solutions market.

Browse 62 market data Tables and 34 Figures spread through 145 Pages and in-depth TOC on "Patient Access Solutions Market by Product & Service (Eligibility Verification, Medical Necessity, Prior-authorization, Denial Management), Delivery Mode (Web & Cloud, On-premise), End User (Providers, Outsourcing Companies) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/patient-access-solution-market-280473.html
Early buyers will receive 10% customization on reports.

“By product & service, the services segment accounted for the largest share of the patient access solutions market in 2016.”

On the basis of product & service, the services segment accounted for the largest share of the global patient access solutions market. The introduction of complex software and the need for system integration are expected to boost the services market in the near future.

“By delivery mode, the web & cloud-based solutions segment accounted for the largest share of the patient access solutions market in 2016.”

On the basis of delivery mode, the web & cloud-based solutions segment accounted for the largest share of the global patient access solutions market. This segment is also exected to grow at the highest CAGR during the forecast period. Factors such as flexibility of working from remote areas, rising affordability, and features such as auto-upgradation are attributing to the larger share and high growth of the web & cloud-based solutions segment.

“By end users, the healthcare providers segment held the largest market share of patient access solutions market in 2016.”

Based on end user, the healthcare providers segment accounted for the largest share of the patient access solutions market. Increasing healthcare IT adoption, increasing affordability in developing countries, and increasing volume of claims denials are the major factors supporting the adoption of patient access solutions in healthcare providers.

https://www.marketsandmarkets.com/pdfdownload.asp?id=280473

“North America dominated the market in 2016.”

North America accounted for the largest share of the patient access solutions market in 2016, followed by Europe and Asia Pacific. North America’s large share in the global market is attributed to factors such as ever-changing healthcare regulations, transition toward high co-pay by patients, increasing government support for improving healthcare IT infrastructure, increasing volume of claims denials, high number of private and government payers, and the presence of a large number of healthcare IT companies.

Prominent players in the patient access solutions market are McKesson (US), Epic Systems (US), Cerner (US), Cognizant (US), Experian (Ireland), Optum (US), Conifer Health (US), The Advisory Board (US), 3M (US), Craneware (UK), The SSI Group (US), ZirMed (US), Cirius Group (US), and AccuReg Software (US).